Chilton Capital Management’s Labcorp LH Stock Holding History

Chilton Capital Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,074	Closed	-$659K	–	185
2020 Q3	$659K	Buy	+4,074	New	+$646K	0.05%	129

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Chilton Capital Management's LH Position: Q1 2026 in Review

Chilton Capital Management sold out of Labcorp (LH) in Q1 2026, closing a stake of 9 shares — an estimated $2.26K sold.

Chilton Capital Management first reported a position in LH in Q2 2014 and held it in 31 quarters. The position peaked at $867K in Q1 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

Chilton Capital Management reported no remaining Labcorp position as of Q1 2026 after selling out during the quarter.
Chilton Capital Management sold 9 Labcorp shares in Q1 2026, an estimated $2.26K.
Chilton Capital Management first reported a position in Labcorp in Q2 2014 and held it in 31 quarters.
Chilton Capital Management's Labcorp position peaked at $867K in Q1 2021.
1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Chilton Capital Management's 13F filing for Q1 2026, filed 11 May 2026.